| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Hiroshi Okubo CEO | JPX Exchange | JP3136800004 ISIN |
| Japan Country | 1,807 Employees | 29 Sep 2026 Last Dividend | 28 Sep 2016 Last Split | - IPO Date |
Ishihara Sangyo Kaisha, Ltd., originating in 1920 and based in Osaka, Japan, positions itself among the leaders in the chemical manufacturing industry on a global scale. The company’s operations are widespread, encompassing not only Japan but also Asia, the United States, Europe, and other international markets. Specializing in both organic and inorganic chemicals, Ishihara Sangyo Kaisha, Ltd. is renowned for its innovative and diversified product range that caters to a vast array of industrial applications.
The TIPAQUE lineup features white pigments extensively used in paints, inks, plastics, and paper, among other applications. These products are crafted to meet high standards of quality and performance, ensuring optimal opacity and brightness.
This range includes ultrafine particles of TiO2 and ZnO, which are vital in various high-tech applications, electro-conductive materials, and glass coatings. Particularly notable are the photocatalytic TiO2 used for self-cleaning surfaces, high purity TiO2 for specific optical requirements, and titanium tetrachloride essential for smoke screens and catalyst carriers.
Focused on environmental sustainability, these products offer solutions like gypsum-based soil conditioners, heavy metal absorbers for soil remediation, and iron oxide-based compounds for decomposing volatile organic compounds (VOCs), presenting comprehensive approaches to pollution control and environmental restoration.
Addressing the needs of modern agriculture, Ishihara Sangyo Kaisha, Ltd. produces a complete range of agrochemicals, including herbicides, fungicides, insecticides, and nematicides. These products are designed to enhance crop protection, ensuring higher yields and improved food security.
The company extends its chemical expertise to the veterinary sector with products like fuzapladib sodium hydrate, an innovative anti-pancreatitis medication for dogs. This reflects Ishihara Sangyo Kaisha, Ltd.'s commitment to improving health and wellbeing across species.
Ishihara Sangyo Kaisha, Ltd. supplies specialized organic intermediates such as CF3-pyridine compounds. These are critical pharmaceutical raw materials, underpinning the synthesis of various drugs and highlighting the company’s role in supporting the pharmaceutical industry.